(Q35012018)

5 August 2017

1 reference

title

Hyperhomocysteinemia as a potential contributor of colorectal cancer development in inflammatory bowel diseases: a review (English)

1 reference

inflammatory bowel diseases

5 August 2017

main subject

0 references

1 reference

1 reference

Ammar Hassanzadeh Keshteli

series ordinal

1

1 reference

5 August 2017

Vickie E Baracos

series ordinal

2

1 reference

5 August 2017

Karen L Madsen

series ordinal

3

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 January 2015

1 reference

World Journal of Gastroenterology

5 August 2017

published in

1 reference

5 August 2017

volume

21

1 reference

5 August 2017

issue

4

1 reference

5 August 2017

page(s)

1081-1090

1 reference

Association of methylenetetrahydrofolate reductase C677T and A1298C polymorphisms with colorectal cancer risk: A meta-analysis

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Homocysteine, cysteine, and risk of incident colorectal cancer in the Women's Health Initiative observational cohort

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Homocysteine imbalance: a pathological metabolic marker

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Effect of Vitamin B(12) and Folate on Homocysteine levels in colorectal cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Hyperhomocysteinemia is a risk factor for colorectal adenoma in women

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Hyperhomocysteinemia and the role of B vitamins in cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Colorectal cancer in patients with inflammatory bowel disease: can we predict risk?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Methylenetetrahydrofolate reductase C677T gene polymorphism and colorectal cancer risk: A case-control study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Etiology of inflammatory bowel disease: a unified hypothesis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Colorectal cancer surveillance in patients with inflammatory bowel disease: What is new?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Managing risks of neoplasia in inflammatory bowel disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Hypothesis: hyperhomocysteinemia is an indicator of oxidant stress

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Inflammatory bowel disease and colon cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Prevalence and risk factors of hyperhomocysteinemia in Tunisian patients with Crohn's disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Dysplasia and cancer in inflammatory bowel disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Canadian Digestive Health Foundation Public Impact Series. Inflammatory bowel disease in Canada: Incidence, prevalence, and direct and indirect economic impact

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Baseline plasma total homocysteine and adenoma recurrence: results from a double blind randomized clinical trial of aspirin and folate supplementation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Ursodeoxycholic acid and chemoprevention of colorectal cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Serum adiponectin, leptin, C-peptide, homocysteine, and colorectal adenoma recurrence in the Polyp Prevention Trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Plasma homocysteine and cysteine and risk of breast cancer in women

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Homocysteine metabolism and its relation to health and disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Genetic variants of homocysteine/folate metabolism pathway and risk of inflammatory bowel disease: a synopsis and meta-analysis of genetic association studies

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Mesalamine protects against colorectal cancer in inflammatory bowel disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Plasma levels of B vitamins and colorectal cancer risk: the multiethnic cohort study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Review article: diet and inflammatory bowel disease--epidemiology and treatment.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

MHC Class II alleles in ulcerative colitis-associated colorectal cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Inflammatory bowel disease: a survey of the epidemiology in Asia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

One-carbon metabolism biomarkers and risk of colon and rectal cancers

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Public health significance of elevated homocysteine

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Polymorphisms of MTHFD, plasma homocysteine levels, and risk of gastric cancer in a high-risk Chinese population.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Total plasma homocysteine and methylenetetrahydrofolate reductase C677T polymorphism in patients with colorectal carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Low folate levels may protect against colorectal cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Folate and prevention of colorectal cancer in ulcerative colitis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Systematic review of microsatellite instability and colorectal cancer prognosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Hyperhomocysteinemia is a risk factor for cancer and a new potential tumor marker

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

A polymorphism in the methylenetetrahydrofolate reductase gene predisposes to colorectal cancers with microsatellite instability

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

The risk of colorectal cancer in ulcerative colitis: a meta-analysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

8 July 2018

Homocysteine metabolism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Serum folate, homocysteine and colorectal cancer risk in women: a nested case-control study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Colonic mucosal concentrations of folate correlate well with blood measurements of folate status in persons with colorectal polyps

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

The elevated homocysteine stimulates changes of haemostatic function of plasma isolated from breast cancer patients.

8 July 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I4.1081

Plasma homocysteine, folate, and vitamin B12 levels in patients with laryngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I4.1081

Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I4.1081

Association of hyperhomocysteinemia and folate deficiency with colon tumors in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I4.1081

High homocysteine is associated with increased risk of colorectal cancer independently of oxidative stress and antioxidant capacities.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I4.1081

Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I4.1081

Prevalence of hyperhomocysteinaemia, activated protein C resistance and prothrombin gene mutation in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I4.1081

Hyperhomocysteinemia and inflammatory bowel disease: prevalence and predictors in a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I4.1081

Hyperproliferation of homocysteine-treated colon cancer cells is reversed by folate and 5-methyltetrahydrofolate

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I4.1081

Microsatellite instability and the association with plasma homocysteine and thymidylate synthase in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I4.1081

Determinants of homocysteine levels in colorectal and breast cancer patients.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Methylation of estrogen receptor alpha and mutL homolog 1 in normal colonic mucosa: association with folate and vitamin B-12 status in subjects with and without colorectal neoplasia.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Colorectal cancer and the methylenetetrahydrofolate reductase 677C -> T and methionine synthase 2756A -> G polymorphisms: a study of 2,168 case-control pairs from the JANUS cohort.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Low vitamin B(6) plasma levels, a risk factor for thrombosis, in inflammatory bowel disease: role of inflammation and correlation with acute phase reactants

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306151

Type 2 diabetes mellitus and colorectal cancer risk: is homocysteine the missing link?

25 October 2018

1 reference

12 December 2020

Changes in the incidence of inflammatory bowel disease: what does it mean?

1 reference

12 December 2020

Red blood cell folate is associated with the development of dysplasia and cancer in ulcerative colitis

1 reference

12 December 2020

Folate fortification, plasma folate, homocysteine and colorectal adenoma recurrence

1 reference

12 December 2020

Crohn's disease and vitamin B12 metabolism

1 reference

12 December 2020

Association between squamous cell carcinoma of the head and neck and serum folate and homocysteine

1 reference

12 December 2020

Impact of the MTHFR C677T polymorphism on colorectal cancer in a population with low genetic variability

1 reference

12 December 2020

Folate and colorectal neoplasia: relation between plasma and dietary markers of folate and adenoma recurrence

1 reference

12 December 2020

Serum folate and homocysteine levels are associated with colon tumorigenesis in end-stage renal disease patients

1 reference

12 December 2020

Biomarkers of platelet activation in acute coronary syndromes

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V21.I4.1081

1 reference

5 August 2017

1 reference

5 August 2017

1 reference